TickerFacts.

A business in context

RAPP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-06 · 0001193125-26-417919

  2. 4 · Ownership change

    Report date 2026-09-30 · 0001193125-26-410734

  3. 4 · Ownership change

    Report date 2026-09-23 · 0001193125-26-401017

  4. 4 · Ownership change

    Report date 2026-09-08 · 0001193125-26-386436

  5. 4 · Ownership change

    Report date 2026-08-25 · 0001193125-26-368285

  6. 4 · Ownership change

    Report date 2026-08-24 · 0001193125-26-368244

  7. 4 · Ownership change

    Report date 2026-08-19 · 0001193125-26-359189

  8. 4 · Ownership change

    Report date 2026-08-10 · 0001193125-26-346995

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-333862

  10. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-333853 · Items 2.02,9.01

  11. 8-K · Current report

    Report date 2026-06-10 · 0001193125-26-265841 · Items 5.07

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-210355

  13. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-210324 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001193125-26-171828

  15. 8-K · Current report

    Report date 2026-04-21 · 0001193125-26-167078 · Items 7.01,8.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-099360

  17. 8-K · Current report

    Report date 2026-03-10 · 0001193125-26-099336 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-01-07 · 0001193125-26-005499 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-01-07 · 0001193125-26-005446 · Items 7.01,8.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-268096

  21. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-268072 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-09-09 · 0001193125-25-200205 · Items 1.01,9.01

  23. 8-K · Current report

    Report date 2025-09-08 · 0001193125-25-198322 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-09-08 · 0001193125-25-197610 · Items 7.01,8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104565

  26. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-104557 · Items 2.02,7.01,9.01

  27. 8-K · Current report

    Report date 2025-06-17 · 0000950170-25-087921 · Items 5.07

  28. 8-K · Current report

    Report date 2025-06-02 · 0000950170-25-080247 · Items 7.01,8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066393

  30. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066376 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-17 · 0001193125-25-092133

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-036828

  33. 8-K · Current report

    Report date 2025-03-11 · 0000950170-25-036822 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-03-03 · 0001193125-25-043405 · Items 7.01,8.01,9.01

  35. 8-K · Current report

    Report date 2025-01-09 · 0001193125-25-004045 · Items 7.01,8.01,9.01

  36. SC 13G/A · Ownership disclosure

    0001172661-24-005064

  37. SC 13G · Ownership disclosure

    0001072613-24-000885

  38. SC 13G · Ownership disclosure

    0001562230-24-000082

  39. SC 13G/A · Ownership disclosure

    0000315066-24-002916

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122801

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 25 transaction rows25SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

25 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-23
2026-09-24
Ceesay AbrahamS · Sale
Disposed
Common Stock43.041.05
2026-09-23
2026-09-24
Ceesay AbrahamS · Sale
Disposed
Common Stock1952.039.05
2026-09-23
2026-09-24
Ceesay AbrahamS · Sale
Disposed
Common Stock215.039.86
2026-09-08
2026-09-09
Ceesay AbrahamS · Sale
Disposed
Common Stock7141.045.56
2026-09-08
2026-09-09
Ceesay AbrahamS · Sale
Disposed
Common Stock1069.046.01
2026-08-25
2026-08-26
Ceesay AbrahamS · Sale
Disposed
Common Stock18921.049.57
2026-08-25
2026-08-26
Yeleswaram KrishnaswamyS · Sale
Disposed
Common Stock16201.051.06
2026-08-25
2026-08-26
Yeleswaram KrishnaswamyS · Sale
Disposed
Common Stock20799.050.31
2026-08-24
2026-08-26
Yeleswaram KrishnaswamyS · Sale
Disposed
Common Stock13160.050.0
2026-08-19
2026-08-20
Yeleswaram KrishnaswamyS · Sale
Disposed
Common Stock404.049.9
2026-08-11
2026-08-12
Ceesay AbrahamS · Sale
Disposed
Common Stock3664.046.9
2026-08-11
2026-08-12
Ceesay AbrahamS · Sale
Disposed
Common Stock19500.048.04
2026-08-11
2026-08-12
Ceesay AbrahamS · Sale
Disposed
Common Stock5794.048.62
2026-08-10
2026-08-12
Ceesay AbrahamS · Sale
Disposed
Common Stock14171.045.97
2026-08-10
2026-08-12
Ceesay AbrahamS · Sale
Disposed
Common Stock8370.046.75
2026-07-27
2026-07-29
Ceesay AbrahamS · Sale
Disposed
Common Stock2203.042.11
2026-07-27
2026-07-29
Ceesay AbrahamS · Sale
Disposed
Common Stock7.042.74
2026-07-14
2026-07-15
Ceesay AbrahamS · Sale
Disposed
Common Stock2729.040.57
2026-07-14
2026-07-15
Ceesay AbrahamS · Sale
Disposed
Common Stock5481.039.72
2026-06-30
2026-07-01
Gault CherylS · Sale
Disposed
Common Stock1000.043.15
2026-06-30
2026-07-01
Gault CherylS · Sale
Disposed
Common Stock3308.042.17
2026-06-30
2026-07-01
Gault CherylS · Sale
Disposed
Common Stock1900.040.09
2026-06-30
2026-07-01
Gault CherylS · Sale
Disposed
Common Stock3792.041.39
2026-06-29
2026-07-01
Ceesay AbrahamS · Sale
Disposed
Common Stock876.040.34
2026-06-29
2026-07-01
Ceesay AbrahamS · Sale
Disposed
Common Stock7344.039.77

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0002012593Rapport Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Rapport Therapeutics, Inc. · former SEC name · 2024-03-27 to 2026-10-08

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗